房颤射频消融术可逆转冠状窦血miRNA的异常表达
The radiofrequency ablation may reverse the abnormal miRNA expression in coronary sinus blood of patients with atrial fibrillation
摘要: 目的 探讨房颤射频消融手术（RFA）终止房颤后患者冠状窦血miRNA的变化，试图发现真正起调控作用的miRNA，以揭示房颤的机制及可能的干预靶点。方法 选择30例行房颤射频消融术患者（阵发性、持续性和永久性房颤各10例），健康体检者10例作为正常对照组。射频消融术前分别取冠状窦血和外周血，术后3个月取外周血，使用miRNA芯片进行全基因组miRNA表达谱微阵列分析，Real-time PCR对miRNA结果进行验证，并通过mirbase、miranda、targetscan数据库行靶基因分析，对重要miRNA进行双荧光素酶结合实验。结果 房颤射频消融术前患者冠状窦血与自身外周血比较，共有142种miRNA表达差异，其中6种显著上调，8种下调（p<0.05）。射频消融术后外周血较术前上调的6种miRNA中分别有3种表达上调和下调，其中miR-1266下调-204.17倍；较术前下调的8种miRNA中，有7种再下调,其中miR-3664-5p下调-44.66倍。荧光素酶结合实验证实SCN5A是miR-1266的直接靶基因，CACNA1C是miR-4279的直接靶基因。结论 房颤射频消融手术可逆转患者冠状窦血miRNA的调控异常，冠状窦血miRNA的表达差异可直接反映房颤时心肌miRNA的表达状况。miR-1266有可能成为未来房颤干预的靶点。
Abstract: Objective: To study the effect of radiofrequency ablation (RFA) on miRNA differential expression in coronary sinus blood (SB) of Atrial Fibrillation (AF) patients, and try to identify the possible pathogenesis of AF and miRNA targets for intervention in future. Methods: 30 AF patients (10 paroxymal, 10 persistent and 10 permanent AF patients) were enrolled, alongside 10 healthy subjects as controls. Peripheral blood (PB) samples were obtained before and at 3 months after RFA respectively. The total RNA was extracted and hybridized with the microRNA chips (microRNA v 18.0), and the differential expression of miRNA and clustering analysis in whole genome were made with Volcano Plot and tMEV software respectively, and validated by Real-time PCR. The target gene analysis of miRNAs was predicted through the Mirbase, Miranda and Targetscan databases. The important miRNAs were made for dual luciferase binding experiment to analyze and validate target genes.Results: There were 142 miRNAs differential expression in SB of pre-operation AF patients compared with PB of patient-self control, in which, 6 miRNAs were increased and 8 miRNAs were decreased significantly (P<0.05). Then, in the compare of PB in AF patients after RFA with which of self-control before RFA, there were 3 miRNAs up-regulated and down-regulated respectively in above increased 6 miRNAs, while miR-1266 was down-regulated 204.17-fold. In above decreased 8 miRNAs, 7 of them were down-regulated again after RFA, while miR-574-3p up-regulated 5.25-fold. SCN5A was the target gene of miR-1266, and CACNA1C was the target gene of miR-4279 confirmed with Luciferase binding experiments. Conclusion: RFA can reverse the abnormal expressions of miRNAs in AF patients. The differential expression of miRNAs in SB can directly reflect the regulatory status of miRNAs in cardiomyocytes in AF attack. MiR-1266 may become the future target for AF intervention.
文章引用：赵楠楠, 徐桂玉, 杨水祥. 房颤射频消融术可逆转冠状窦血miRNA的异常表达[J]. 汉斯预印本, 2016, 1(1): 1-14. http://dx.doi.org/10.12677/HANSPrePrints.2016.11006

参考文献

[1] Aylin Hatice Yamac, Sitki Kucukbuzcu, Mehmet Ozansoy, et al. Altered expression of micro-RNA 199a and increased levels of cardiac SIRT1 protein are associated with the occurrence of atrial fibrillation after coronary artery bypass graft surgery. Cardiovascular Pathology, In Press, Accepted Manuscript, Available online 12 February 2016
[2] Abdelnaby Khalyfa, Leila Kheirandish-Gozal, Rakesh Bhattacharjee, et al. Circulating miRNAs as Potential Biomarkers of Endothelial Dysfunction In Obese Children. Chest, In Press, Accepted Manuscript, Available online 12 January 2016
[3] Ludwig T Weckbach, Ulrich Grabmaier, Sebastian Clauss, et al. MicroRNAs as a diagnostic tool for heart failure and atrial fibrillation. Current Opinion in Pharmacology, Volume 27, April 2016, Pages 24-30
[4] Kentaro Takahashi, Tetsuo Sasano, Koji Sugiyama, et al. High-fat diet increases vulnerability to atrial arrhythmia by conduction disturbance via miR-27b. Journal of Molecular and Cellular Cardiology, Volume 90, January 2016, Pages 38-46
[5] Bianca C. Bernardo, Burns C. Blaxall. From Bench to Bedside: New approaches to therapeutic discovery for heart failure. Heart, Lung and Circulation, In Press, Uncorrected Proof, Available online 19 January 2016
[6] Syed Salman Ali, Chandra Kala, Mohd Abid, et al. Pathological microRNAs in acute cardiovascular diseases and microRNA therapeutics Journal of Acute Disease, Volume 5, Issue 1, 1 January 2016, Pages 9-15
[7] Li M, Zhang J. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases. Biomed Res Int. 2015;2015:730535.
[8] Orenes-Piñero E, Quintana-Giner M, Romero-Aniorte AI, et al. Novel biomarkers in cardiology: MicroRNAs in atrial fibrillation. Arch Cardiol Mex. 2015; 15:00031-00032.
[9] 杨水祥，徐桂玉，赵楠楠等.心房颤动患者冠状窦血小分子RNA表达差异与价值.中华老年心脑血管病杂志.2014;16(7):726-731.
[10] Zhao Y, Huang Y, Li W,et al. Post-transcriptional regulation of cardiac sodium channel gene SCN5A expression and function by miR-192-5p. Biochim Biophys Acta. 2015;1852(10 Pt A):2024-2034.
[11] Ziyadeh-Isleem A, Clatot J, Duchatelet S, et al.A truncating SCN5A mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation.Heart Rhythm.2014;11(6):1015-1023.
[12] Kyle JW, Makielski JC.Diseases caused by mutations in Nav1.5 interacting proteins.Cardiac Electrophysiol Clinics.2014;6(4):797-809.
[13] Poulet C, Wettwer E, Grunnet M, et al. Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation. PLoS One. 2015;10(6):e0131432.
[14] Aguilar M, Nattel S. The past, present and potential future of sodium channel block as an atrial fibrillation suppressing strategy. J Cardiovasc Pharmacol. 2015.
[15] Savio-Galimberti E, Weeke P, Muhammad R, et al. SCN10A/Nav1.8 modulation of peak and late sodium currents in patients with early onset atrial fibrillation. Cardiovasc Res. 2014;104(2):355-363.
[16] Yue L, Melnyk P, Gaspo R, et al. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res. 1999;84(7):776-784.
[17] Gaspo R, Bosch RF, Talajic M, Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation. 1997;96(11):4027-4035.
[18] Sossalla S, Kallmeyer B, Wagner S,et al. Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol. 2010;55(21):2330-2342.
[19] Liebeskind BJ, Hillis DM, Zakon HH. Phylogeny unites animal sodium leak channels with fungal calcium channels in an ancient, voltage-insensitive clade. Mol Biol Evol. 2012;29(12):3613-3616.
[20] Chang YS, Yang YW, Lin YN, et al. Mutation Analysis of KCNQ1, KCNH2 and SCN5A Genes in Taiwanese Long QT Syndrome Patients. Int Heart J. 2015;56(4):450-453.
[21] Wang QS, Wang XF, Chen XD, et al. Genetic polymorphism of KCNH2 confers predisposition of acquired atrial fibrillation in Chinese. J Cardiovasc Electrophysiol. 2009;20(10):1158-1162.
[22] Hong K, Bjerregaard P, Gussak I, Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol. 2005;16(4):394-396.
[23] Gorshkova ES, Minushkina LO, Brovkin AN, et al. Genetic predisposition to development of atrial fibrillation in patients with hypertensive disease. Kardiologiia. 2010;50(5):19-24.
[24] Yang BF, Du ZM, Kohei S. Frequency- and voltage-dependent inhibition of delayed outward potassium current by flecainide in isolated atrial cell of guinea pig heart. Zhongguo Yao Li Xue Bao. 1994;15(1):28-32.
[25] Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119(1):19-31.
[26] Lu Y, Zhang Y, Wang N, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation;122(23):2378-2387.
[27] Soon JL, Ping L, Chua YL, et al. Absence of calcium channel alpha1C-subunit mutation in human atrial fibrillation. Asian Cardiovasc Thorac Ann. 2010;18(4):349-353.
[28] Greiser M, Halaszovich CR, Frechen D,et al. Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol. 2007;375(6):383-392.
[29] Hsueh CH, Chang PC, Hsieh YC, et al. Proarrhythmic effect of blocking the small conductance calcium activated potassium channel in isolated canine left atrium. Heart Rhythm. 2013;10(6):891-898.
[30] Ellinor PT1, Lunetta KL, Glazer NL, et al.Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet. 2010;42(3):240-244.
[31] Ellinor PT1, Lunetta KL, Albert CM,et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012;44(6):670-675.
[32] Jiménez-Garduño AM, Mitkovski M, Alexopoulos IK,et al. KV10.1 K(+)-channel plasma membrane discrete domain partitioning and its functional correlation in neurons. Biochim Biophys Acta. 2014;1838(3):921-931.
[33] Sano Y, Mochizuki S, Miyake A,et al. Molecular cloning and characterization of Kv6.3, a novel modulatory subunit for voltage-gated K(+) channel Kv2.1. FEBS Lett. 2002 Feb 13;512(1-3):230-234.
[34] Fantozzi I, Platoshyn O, Wong AH,et al. Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2006;291(5):L993-1004.
[35] Li JY, Wang HJ, Xu B,et al. Hyperpolarization activated cation current (I(f)) in cardiac myocytes from pulmonary vein sleeves in the canine with atrial fibrillation. J Geriatr Cardiol. 2012;9(4):366-374.
[36] Aguilar M, Qi XY, Huang H,et al. Fibroblast electrical remodeling in heart failure and potential effects on atrial fibrillation.Biophys J. 2014,107(10):2444-2455.
[37] He XZ, Wang HY, Shen Y,et al. Cardiomyocyte progenitors in a canine pulmonary vein model of persistent atrial fibrillation. J Cardiol. 2012,60(3):242-247.
[38] Biliczki P, Girmatsion Z, Brandes RP,et al. Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction. Heart Rhythm. 2009;6(12):1792-1801.
[39] Liin SI, Silverå Ejneby M, Barro-Soria R,et al. Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel. Proc Natl Acad Sci U S A. 2015;112(18):5714-5719.
[40] Cheng CJ, Sung CC, Wu ST,et al. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance. J Clin Endocrinol Metab. 2015;100(1):E155-163.
[41] Han HG, Wang HS, Yin Z,et al. KCNE1 112G>a polymorphism and atrial fibrillation risk: a meta-analysis. Genet Mol Res. 2014;13(4):8367-8377.
[42] Li YY, Wang LS, Lu XZ. Mink S38G gene polymorphism and atrial fibrillation in the Chinese population: a meta-analysis of 1871 participants. Scientific World Journal. 2014;2014:768681.
[43] Liang C, Li X, Xu Y,et al. KCNE1 rs1805127 polymorphism increases the risk of atrial fibrillation: a meta-analysis of 10 studies. PLoS One. 2013;8(7):e68690.
[44] Fantozzi I, Platoshyn O, Wong AH,et al. Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2006;291(5):L993-1004.
[45] Weiss J, Pyrski M, Weissgerber P, Zufall F. Altered synaptic transmission at olfactory and vomeronasal nerve terminals in mice lacking N-type calcium channel Cav2.2. Eur J Neurosci. 2014;40(10):3422-3435.
[46] Schwartz RJ, Schneider MD. CAMTA in cardiac hypertrophy. Cell. 2006;125(3):427-429.
[47] Song K1, Backs J, McAnally J,et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell. 2006;125(3):453-466.
[48] Bosch RF, Zeng XR, G ramm er JB, et a l. Ionic mechanisms of electrical remodeling in human atrial fib- rillation. Cardiovasc Res,1999, 44:121-131.
[49] Allessie M A,Boyden P A,Camm A J,et al.Pathophysiology and prevention of atrial fibrillation.Circulation,2001,103:769-777.
[50] Nattel S, Frelin Y, Gaborit N,et al. Ion-channel mRNA-expression profiling: Insights into cardiac remodeling and arrhythmic substrates. J Mol Cell Cardiol. 2010;48(1):96-105.
[51] McManus DD, Tanriverdi K, Lin H. Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study). Heart Rhythm. 2015;12(1):3-10.